Literature DB >> 9863825

Parathyroid hormone and corticosteroid-induced osteoporosis.

S C Manolagas, R S Weinstein, R L Jilka, A M Parfitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9863825     DOI： 10.1016/S0140-6736(05)60443-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers.

Authors:  Sungtae Kim; Miwa Yamazaki; Lee A Zella; Nirupama K Shevde; J Wesley Pike
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

2.  Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.

Authors:  Robert S Weinstein; Robert L Jilka; Maria Almeida; Paula K Roberson; Stavros C Manolagas
Journal:  Endocrinology       Date:  2010-04-21       Impact factor: 4.736

3.  Retreatment with teriparatide one year after the first teriparatide course in patients on continued long-term alendronate.

Authors:  Felicia Cosman; Jeri W Nieves; Marsha Zion; Nancy Barbuto; Robert Lindsay
Journal:  J Bone Miner Res       Date:  2009-06       Impact factor: 6.741
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.